Availability of Drugs and Resistance Testing for Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin (Bpal(M)) Regimen for Rifampicin-Resistant Tuberculosis in Europe: Author's Response

AuthID
 P-016-XX7
5
Author(s)
Lange, C
·
Kherabi, Y
·
Guglielmetti, L
·
Günther, G
1
Group Author(s)
Tuberculosis Network European Trials Grp
Document Type
Letter
Year published
2024
Published
in CLINICAL MICROBIOLOGY AND INFECTION, ISSN: 1198-743X
Volume: 30, Issue: 9, Pages: 1207-1208 (2)
Indexing
Wos®
Pubmed®
Publication Identifiers
Pubmed: 38901496
Wos: WOS:001302175500001
Source Identifiers
ISSN: 1198-743X
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service